300981 中红医疗
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.897-2.2021.05651.4151.760
总资产报酬率 ROA (%)0.706-1.8870.95843.271112.180
投入资产回报率 ROIC (%)0.765-2.0271.02046.90678.744

边际利润分析
销售毛利率 (%)12.86012.0999.69661.55870.833
营业利润率 (%)3.443-6.502-0.69956.78766.826
息税前利润/营业总收入 (%)2.191-8.325-0.63756.89368.746
净利润/营业总收入 (%)2.991-6.0644.25947.70355.741

收益指标分析
经营活动净收益/利润总额(%)66.233-13.72297.155101.27899.484
价值变动净收益/利润总额(%)80.843-60.252128.1342.9640.152
营业外收支净额/利润总额(%)-1.5160.579121.445-0.128-0.041

偿债能力分析
流动比率 (X)3.0475.1906.9059.2122.419
速动比率 (X)2.6574.5356.2508.3922.130
资产负债率 (%)22.00616.18210.0358.35530.413
带息债务/全部投入资本 (%)16.96410.9843.5852.227--
股东权益/带息债务 (%)485.922804.8032,672.0204,368.595373.276
股东权益/负债合计 (%)345.236505.107894.5751,096.821228.806
利息保障倍数 (X)-1.8254.6620.163317.71235.306

营运能力分析
应收账款周转天数 (天)64.10051.63256.23622.3160.000
存货周转天数 (天)91.72090.123112.20874.5600.000